%0 Journal Article
%T Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
%A Giancarlo Agnelli
%A Gianpaolo Reboldi
%A Maria Cristina Vedovati
%A Paolo Verdecchia
%A on Behalf of the Umbria-Fibrillazione Atriale Investigators *
%J Archive of "TH Open: Companion Journal to Thrombosis and Haemostasis".
%D 2019
%R 10.1055/s-0039-1692202
%X Background £¿Valvular heart disease (VHD) and atrial fibrillation (AF) often coexist
%K atrial fibrillation
%K valvular heart disease
%K vitamin K antagonists
%K non¨Cvitamin K oral anticoagulants
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598085/